Pharmacokinetics and tolerance of zidovudine in preterm infants
Edmund V. Capparelli(University of California San Diego), James D. Connor, Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Betsy Smith(National Institute of Allergy and Infectious Diseases), Wayne M. Dankner(University of California San Diego), Gregory Ciupak(Rutgers, The State University of New Jersey), Suzette Blanchard(Rutgers, The State University of New Jersey), George McSherry(Rutgers New Jersey Medical School), Mark Mirochnick(Boston University), Hannah Gay(Jackson Memorial Hospital)
Cited by 84
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|697